Bidirectional Regulation of Human Colonic Smooth Muscle Contractility by Tachykinin NK2 Receptors
Authors:
Open Access
- 1 January 2011
- journal article
- Published by Japanese Pharmacological Society in Journal of Pharmacological Sciences
- Vol. 117 (2) , 106-115
Abstract
In this study, we attempted to clarify the mechanism of tachykinin-induced motor response in isolated smooth muscle preparations of the human colon. Fresh specimens of normal colon were obtained from patients suffering from colonic cancer. Using mucosa-free smooth muscle strips, smooth muscle tension with circular direction was monitored isometrically. Substance P (SP), neurokinin A (NKA), and neurokinin B (NKB) produced marked contraction. All of these contractions were inhibited by saredutant, a selective NK2-R antagonist, but not by CP122721, a selective NK1-R antagonist or talnetant, a selective NK3-R antagonist. βAla8-NKA(4-10) induced concentration-dependent contraction similar to NKA, but Sar9-Met11-SP and Met-Phe7-NKB did not cause marked contraction. Colonic contraction induced by βAla8-NKA(4-10) was completely blocked by saredutant, but not by atropine. Tetrodotoxin or NG-nitro-L-arginine methyl ester pretreatment significantly enhanced βAla8-NKA(4-10)–induced contraction. Immunohistochemical analysis showed that the NK2-R was expressed on the smooth muscle layers and myenteric plexus where it was also co-expressed with neuronal nitric oxide synthase in the myenteric plexus. These results suggest that the NK2-R is a major contributor to tachykinin-induced smooth muscle contraction in human colon and that the NK2-R–mediated response consists of an excitatory component via direct action on the smooth muscle and an inhibitory component possibly via nitric oxide neurons.Keywords
This publication has 29 references indexed in Scilit:
- Multifaceted Approach to Determine the Antagonist Molecular Mechanism and Interaction of Ibodutant ([1-(2-Phenyl-1R-{[1-(tetrahydropyran-4-ylmethyl)-piperidin-4-ylmethyl]-carbamoyl}-ethylcarbamoyl)-cyclopentyl]-amide) at the Human Tachykinin NK2 ReceptorThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Distribution pattern of tachykinin NK2 receptors in human colon: Involvement in the regulation of intestinal motilityJournal of Comparative Neurology, 2007
- Peripheral tachykinin receptors as potential therapeutic targets in visceral diseasesExpert Opinion on Therapeutic Targets, 2003
- A novel tachykinin NK2 receptor antagonist prevents motility‐stimulating effects of neurokinin A in small intestineBritish Journal of Pharmacology, 2001
- Contractile Responses to Natural Tachykinins and Selective Tachykinin Analogs in Normal and Inflamed Ileal and Colonic MuscleScandinavian Journal of Gastroenterology, 2001
- In vitro characterization of tachykinin NK2‐receptors modulating motor responses of human colonic muscle stripsBritish Journal of Pharmacology, 1998
- Tachykinin receptors and intestinal motilityCanadian Journal of Physiology and Pharmacology, 1997
- Tachykinin-induced contractions of the guinea pig ileum longitudinal smooth muscle: tonic and phasic muscular activitiesCanadian Journal of Physiology and Pharmacology, 1997
- The mammalian tachykinin receptorsGeneral Pharmacology: The Vascular System, 1995
- A potent and selective non-peptide antagonist of the neurokinin a (NK2) receptorLife Sciences, 1992